← Leaderboards
Hong Zheng
University Of Nebraska Medical Center
$2,028,218
Attributed
$4,056,436
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $925.2K · FY2017–24$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,056,436 · 2
By mechanism
R01$4,056,436 · 2
Top collaborators
- Kaushik P Patel9 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Irving H Zucker$21,983,867
- Hanjun Wang$9,874,791
- Yu-Long Li$10,009,035
- Steven Sansom$6,763,098
- Kaushik P Patel$11,800,516
Others in their field
Other Emerging Leaders on “Norepinephrine”
- Heidi Irma Jacobs · Massachusetts General Hospital$5,035,742
- Steven P Cohen · Johns Hopkins University$4,637,929
- Hongdian Yang · University Of California Riverside$3,601,449
- Matthew A Nystoriak · University Of Louisville$3,120,241
- Tina Louise Vrabec · Case Western Reserve University$3,017,349
- Traci Taylor Goodchild · Lsu Health Sciences Center$2,886,368
Research focus
NorepinephrineNerveNauseaMolecularLiquid SubstanceMethodologyMolecular Biology TechniquesFatigueImpairmentKidneyEdemaCellsMediatingMeasurementEquilibriumCongestive Heart FailureCanis FamiliarisDenervationAnimalsHemodynamicsDisease ProgressionInsightDyspneaPhysiological
Grant awards (9)
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$478,112
R01 · FY2024 · DK
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$498,034
R01 · FY2023 · DK
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$498,034
R01 · FY2022 · DK
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure$510,235
R01 · FY2021 · DK
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,955
R01 · FY2021 · DK
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,955
R01 · FY2020 · DK
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,955
R01 · FY2019 · DK
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$414,712
R01 · FY2018 · DK
Novel Target Mechanism (Renal Denervation) to Reduce Sodium Retention in Chronic Heart Failure$412,444
R01 · FY2017 · DK